Management of male breast cancer Journal Article


Author: Kinne, D. W.
Article Title: Management of male breast cancer
Abstract: Male breast cancer afflicts about 900 men a year in the U.S., of whom 300 die of their disease. General recommendations for treatment are similar to those for females: All patients with positive nodes and selected node-negative patients considered at high risk for recurrence are advised to have systemic therapy. Tamoxifen is often recommended because the majority of male breast cancers are estrogen and progesterone-receptor positive. No significant experience has been reported with primary radiation therapy to date.
Keywords: review; multimodality cancer therapy; combined modality therapy; breast neoplasms; breast tumor; human; male
Journal Title: Oncology (Norwalk)
Volume: 5
Issue: 3
ISSN: 0890-9091
Publisher: C M P Medica LLC * The Oncology Group  
Date Published: 1991-03-01
Start Page: 45
End Page: 47; discussion 47-48
Language: English
PUBMED: 1829945
PROVIDER: scopus
DOI/URL:
Notes: Review -- Export Date: 27 September 2019 -- Source: Scopus
Citation Impact
MSK Authors
  1. David Kinne
    64 Kinne